Bionano Genomics, Inc.

NasdaqCM:BNGO Stock Report

Market Cap: US$64.1m

Bionano Genomics Management

Management criteria checks 3/4

Bionano Genomics' CEO is Robert Holmlin, appointed in Jan 2011, has a tenure of 13.33 years. total yearly compensation is $1.25M, comprised of 47.7% salary and 52.3% bonuses, including company stock and options. directly owns 0.094% of the company’s shares, worth $60.54K. The average tenure of the management team and the board of directors is 2.3 years and 5 years respectively.

Key information

Robert Holmlin

Chief executive officer

US$1.3m

Total compensation

CEO salary percentage47.7%
CEO tenure13.3yrs
CEO ownership0.09%
Management average tenure2.3yrs
Board average tenure5yrs

Recent management updates

Recent updates

Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Earnings Pushing Shares 31% Lower

May 09
Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Earnings Pushing Shares 31% Lower

Bionano Genomics, Inc. (NASDAQ:BNGO) Analysts Just Trimmed Their Revenue Forecasts By 9.0%

Mar 14
Bionano Genomics, Inc. (NASDAQ:BNGO) Analysts Just Trimmed Their Revenue Forecasts By 9.0%

Bionano Genomics: Little Clinical Utility And A Whole Lot Of Burn

Oct 18

Bionano stock dips amid launch of Bionano Laboratories for optical genome mapping tests

Sep 23

Bionano jumps 36% as publication highlights optical genome mapping

Aug 11

Bionano stock down ~8% after hours; co reports Q2 revenue beat, wider loss

Aug 04

Bionano gets US patent for analysis of nucleic acid fragments for genetic abnormalities

Jun 29

I'm More Positive But Selling Puts Instead Of Buying Bionano Genomics

Jun 23

Here's Why We're Not Too Worried About Bionano Genomics' (NASDAQ:BNGO) Cash Burn Situation

Apr 11
Here's Why We're Not Too Worried About Bionano Genomics' (NASDAQ:BNGO) Cash Burn Situation

CEO Compensation Analysis

How has Robert Holmlin's remuneration changed compared to Bionano Genomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$1mUS$599k

-US$232m

Sep 30 2023n/an/a

-US$227m

Jun 30 2023n/an/a

-US$147m

Mar 31 2023n/an/a

-US$140m

Dec 31 2022US$3mUS$544k

-US$133m

Sep 30 2022n/an/a

-US$117m

Jun 30 2022n/an/a

-US$106m

Mar 31 2022n/an/a

-US$92m

Dec 31 2021US$8mUS$484k

-US$72m

Sep 30 2021n/an/a

-US$61m

Jun 30 2021n/an/a

-US$51m

Mar 31 2021n/an/a

-US$41m

Dec 31 2020US$708kUS$376k

-US$41m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$33m

Mar 31 2020n/an/a

-US$32m

Dec 31 2019US$899kUS$404k

-US$30m

Sep 30 2019n/an/a

-US$28m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$3mUS$390k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$18m

Mar 31 2018n/an/a

-US$22m

Dec 31 2017US$605kUS$379k

-US$23m

Compensation vs Market: Robert's total compensation ($USD1.25M) is above average for companies of similar size in the US market ($USD674.55K).

Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.

CEO

Robert Holmlin (55 yo)

13.3yrs

Tenure

US$1,254,658

Compensation

Dr. Robert Erik Holmlin, Ph D., M.B.A. has been the Chief Executive Officer and President of BioNano Genomics, Inc. (alternatively BioNanomatrix, Inc.) since January 12, 2011 and served as its Secretary. D...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Holmlin
President13.3yrsUS$1.25m0.094%
$ 60.5k
Mark Oldakowski
Chief Operating Officer6.5yrsUS$884.78k0.061%
$ 39.0k
Alka Chaubey
Chief Medical Officer3.8yrsUS$864.78k0.047%
$ 30.2k
Gulsen Kama
Chief Financial Officerless than a yearno datano data
Mark Adamchak
VP of Accounting & Controller5.9yrsno datano data
Jonathan Dixon
General Counsel & Secretary2.2yrsno data0.0053%
$ 3.4k
Stanislas Marin
Vice President of Global Sales2.3yrsno datano data
Donna Polizio
Global Head of Market Access1.5yrsno datano data
Cory Kreeck
Global Head of People Operations2.3yrsno datano data
Klint Rose
Head of Research & Developmentless than a yearno datano data

2.3yrs

Average Tenure

50yo

Average Age

Experienced Management: BNGO's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Holmlin
President13.3yrsUS$1.25m0.094%
$ 60.5k
Christopher Twomey
Independent Director5.8yrsUS$72.75k0.0097%
$ 6.2k
David Barker
Independent Chairman of the Board14yrsUS$97.75k0.0087%
$ 5.6k
Albert Luderer
Independent Director12.6yrsUS$77.75k0%
$ 0
Hannah Mamuszka
Independent Director4yrsUS$60.25k0.0098%
$ 6.3k
Kristiina Vuori
Independent Director5yrsUS$70.25k0%
$ 0
Yvonne Linney
Independent Director4yrsUS$57.75k0%
$ 0
Vincent Wong
Independent Director2.4yrsUS$62.75k0%
$ 0
Aleksandar Rajkovic
Independent Director2.3yrsUS$57.75k0%
$ 0

5.0yrs

Average Tenure

58yo

Average Age

Experienced Board: BNGO's board of directors are considered experienced (5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.